BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu H, Liu S, Bastacky SI, Wang X, Tian XJ, Zhou D. Diabetic kidney diseases revisited: A new perspective for a new era. Mol Metab. 2019;30:250-263. [PMID: 31767176 DOI: 10.1016/j.molmet.2019.10.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 22.7] [Reference Citation Analysis]
Number Citing Articles
1 Dong J, Liu S, Li Q, Wu L, Zhang C, Duan S, Zhang B, Yuan Y, Huang Z, Xing C, Mao H. The association of RNA-binding protein Human antigen R with kidney clinicopathologic features and renal outcomes in patients with diabetic nephropathy. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.110142] [Reference Citation Analysis]
2 Lv X, Zhou M, Liu X, Xiang Q, Yu R. Efficacy and Safety of Zhenwu Decoction in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2022;2022:2133705. [PMID: 36387355 DOI: 10.1155/2022/2133705] [Reference Citation Analysis]
3 Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder RE, Halabi A, Schnell O, Streckbein M, Tuttle KR. New strategies to improve clinical outcomes for diabetic kidney disease. BMC Med 2022;20:337. [PMID: 36210442 DOI: 10.1186/s12916-022-02539-2] [Reference Citation Analysis]
4 Chen J, Peng H, Chen C, Wang Y, Sang T, Cai Z, Zhao Q, Chen S, Lin X, Eling T, Wang X. NAG-1/GDF15 inhibits diabetic nephropathy via inhibiting AGE/RAGE-mediated inflammation signaling pathways in C57BL/6 mice and HK-2 cells. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.121142] [Reference Citation Analysis]
5 Shen Y, Xie L, Chen X, Mao L, Qin Y, Lan R, Yang S, Hu J, Li X, Ye H, Luo W, Gong L, Li Q, Mao Y, Wang Z. Renal fat fraction is significantly associated with the risk of chronic kidney disease in patients with type 2 diabetes. Front Endocrinol 2022;13:995028. [DOI: 10.3389/fendo.2022.995028] [Reference Citation Analysis]
6 Iizuka K. Commentary: Comprehensive lipidome profiling of the kidney in early-stage diabetic nephropathy. Front Endocrinol 2022;13:1015305. [DOI: 10.3389/fendo.2022.1015305] [Reference Citation Analysis]
7 Park G, Choi B, Kang S, Kim B, Chang MJ. Sodium–Glucose Cotransporter-2 Inhibitors Could Help Delay Renal Impairment in Patients with Type 2 Diabetes: A Real-World Clinical Setting. JCM 2022;11:5259. [DOI: 10.3390/jcm11185259] [Reference Citation Analysis]
8 Muntean C, Starcea IM, Banescu C. Diabetic kidney disease in pediatric patients: A current review. World J Diabetes 2022; 13(8): 587-599 [DOI: 10.4239/wjd.v13.i8.587] [Reference Citation Analysis]
9 Sankrityayan H, Kale A, Shelke V, Gaikwad AB. Cyproheptadine, a SET7/9 inhibitor, reduces hyperglycaemia-induced ER stress alleviating inflammation and fibrosis in renal tubular epithelial cells. Arch Physiol Biochem 2022;:1-9. [PMID: 35913792 DOI: 10.1080/13813455.2022.2105365] [Reference Citation Analysis]
10 Wang Z, Guo J. The role of vitamin D receptor agonist on podocyte injury induced by high glucose. Diabetic Nephropathy 2022;0. [DOI: 10.2478/dine-2022-0010] [Reference Citation Analysis]
11 Collazos-huamán LDC, Guerreros-espino C, Herrera-añazco P, Benites-zapata VA. Association between glycemic control and albuminuria among Peruvian adults with diabetes mellitus 2: a cross-sectional analytical study. Sao Paulo Med J . [DOI: 10.1590/1516-3180.2021.0448.r2.07022022] [Reference Citation Analysis]
12 Shu Z, Chen S, Xiang H, Wu R, Wang X, Ouyang J, Zhang J, Liu H, Chen AF, Lu H. AKT/PACS2 Participates in Renal Vascular Hyperpermeability by Regulating Endothelial Fatty Acid Oxidation in Diabetic Mice. Front Pharmacol 2022;13:876937. [DOI: 10.3389/fphar.2022.876937] [Reference Citation Analysis]
13 Shahzad K, Fatima S, Khawaja H, Elwakiel A, Gadi I, Ambreen S, Zimmermann S, Mertens PR, Biemann R, Isermann B. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease. Kidney Int 2022:S0085-2538(22)00513-0. [PMID: 35779608 DOI: 10.1016/j.kint.2022.06.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Shen S, Ji C, Wei K. Cellular Senescence and Regulated Cell Death of Tubular Epithelial Cells in Diabetic Kidney Disease. Front Endocrinol 2022;13:924299. [DOI: 10.3389/fendo.2022.924299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Chang J, Zheng J, Gao X, Dong H, Yu H, Huang M, Sun Z, Feng X. TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway. Front Endocrinol (Lausanne) 2022;13:888611. [PMID: 35721758 DOI: 10.3389/fendo.2022.888611] [Reference Citation Analysis]
16 Bian C, Ren H. Sirtuin Family and Diabetic Kidney Disease. Front Endocrinol 2022;13:901066. [DOI: 10.3389/fendo.2022.901066] [Reference Citation Analysis]
17 Wu B, Chen L, Xu Y, Duan Q, Zheng Z, Zheng Z, He D. The Effect of Allopurinol on Renal Outcomes in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis. Kidney Blood Press Res 2022;47:291-9. [PMID: 35130544 DOI: 10.1159/000522248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang L, Li W, Gong M, Zhang Z, Xue X, Mao J, Zhang H, Li S, Liu X, Wu F, Shi J, Fu G. C-reactive protein inhibits C3a/C3aR-dependent podocyte autophagy in favor of diabetic kidney disease. FASEB J 2022;36:e22332. [PMID: 35503088 DOI: 10.1096/fj.202200198R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li X, Xu B, Wu J, Pu Y, Wan S, Zeng Y, Wang M, Luo L, Zhang F, Jiang Z, Xu Y, Srivastava S. Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/7177889] [Reference Citation Analysis]
20 Robertson L, Vieira R, Butler J, Johnston M, Sawhney S, Black C. Identifying multimorbidity clusters in an unselected population of hospitalised patients. Sci Rep 2022;12:5134. [PMID: 35332197 DOI: 10.1038/s41598-022-08690-3] [Reference Citation Analysis]
21 Savant PB, Kareppa MS, Karwa PN, Birajdar N, Jangid MS. Herbal Drugs used in the Management of Diabetic Nephropathy. AJPR 2022. [DOI: 10.52711/2231-5691.2022.00009] [Reference Citation Analysis]
22 Gomez DM. Diabetic Kidney Disease. Physician Assistant Clinics 2022. [DOI: 10.1016/j.cpha.2021.11.015] [Reference Citation Analysis]
23 Rodríguez-comas J, Ramón-azcón J. Islet-on-a-chip for the study of pancreatic β-cell function. In vitro models 2022;1:41-57. [DOI: 10.1007/s44164-021-00005-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang H, Wang P, Shi D, Yao X, Li Y, Liu X, Sun Y, Ding J, Wang S, Wang G, Ren K. Capability of intravoxel incoherent motion and diffusion tensor imaging to detect early kidney injury in type 2 diabetes. Eur Radiol 2022. [PMID: 35031840 DOI: 10.1007/s00330-021-08415-6] [Reference Citation Analysis]
25 Ni WJ, Guan XM, Zeng J, Zhou H, Meng XM, Tang LQ. Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway. J Cell Mol Med 2022. [PMID: 35001506 DOI: 10.1111/jcmm.17167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Williams ME, Stanton RC. Nutritional and metabolic management of the diabetic patient with chronic kidney disease and chronic renal failure. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00006-9] [Reference Citation Analysis]
27 Xu T, Xu X, Zhang L, Zhang K, Wei Q, Zhu L, Yu Y, Xiao L, Lin L, Qian W, Wang J, Ke M, An X, Liu S. Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy. Front Endocrinol (Lausanne) 2021;12:781417. [PMID: 34956093 DOI: 10.3389/fendo.2021.781417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Kaur V, Kalyani CV, Rohilla KK. Practices followed by type-II diabetes mellitus patients for prevention of foot ulcers. J Family Med Prim Care 2021;10:3732-7. [PMID: 34934673 DOI: 10.4103/jfmpc.jfmpc_486_21] [Reference Citation Analysis]
29 Wen Y, Liu Y, Huang Q, Liu R, Liu J, Zhang F, Liu S, Jiang Y. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway. Phytomedicine 2021;95:153856. [PMID: 34856477 DOI: 10.1016/j.phymed.2021.153856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Liu S, Gui Y, Wang MS, Zhang L, Xu T, Pan Y, Zhang K, Yu Y, Xiao L, Qiao Y, Bonin C, Hargis G, Huan T, Yu Y, Tao J, Zhang R, Kreutzer DL, Zhou Y, Tian XJ, Wang Y, Fu H, An X, Liu S, Zhou D. Serum integrative omics reveals the landscape of human diabetic kidney disease. Mol Metab 2021;54:101367. [PMID: 34737094 DOI: 10.1016/j.molmet.2021.101367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Ahmad AA, Draves SO, Rosca M. Mitochondria in Diabetic Kidney Disease. Cells 2021;10:2945. [PMID: 34831168 DOI: 10.3390/cells10112945] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
32 Shigidi MM, Karrar WN. Risk factors associated with the development of diabetic kidney disease in Sudanese patients with type 2 diabetes mellitus: A case-control study. Diabetes Metab Syndr 2021;15:102320. [PMID: 34700293 DOI: 10.1016/j.dsx.2021.102320] [Reference Citation Analysis]
33 Mutter S, Valo E, Aittomäki V, Nybo K, Raivonen L, Thorn LM, Forsblom C, Sandholm N, Würtz P, Groop PH. Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes. Diabetologia 2021. [PMID: 34686904 DOI: 10.1007/s00125-021-05584-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
34 Liang D, Mai H, Ruan F, Fu H. The Efficacy of Triptolide in Preventing Diabetic Kidney Diseases: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:728758. [PMID: 34658869 DOI: 10.3389/fphar.2021.728758] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Bhattacharya S, Kalra S, Kapoor N, Singla R, Dutta D, Aggarwal S, Khandelwal D, Surana V, Dhingra A, Kantroo V, Chittawar S, Deka N, Bindal V, Dutta P. Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery. World J Diabetes 2021; 12(10): 1587-1621 [PMID: 34754367 DOI: 10.4239/wjd.v12.i10.1587] [Reference Citation Analysis]
36 Bao L, Gao X, Xie K, Li Y. Is There a Diabetes-Kidney-Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors. Front Cardiovasc Med 2021;8:716083. [PMID: 34631819 DOI: 10.3389/fcvm.2021.716083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhao S, Zhou L, Tao Y, Yue Y, Wang J, Shen L, Lu G, Hang Y. Renal outcomes in Asian patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a systematic review and meta-analysis of randomized controlled trials. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-00999-5] [Reference Citation Analysis]
38 Lazar AG, Vlad ML, Manea A, Simionescu M, Manea SA. Activated Histone Acetyltransferase p300/CBP-Related Signalling Pathways Mediate Up-Regulation of NADPH Oxidase, Inflammation, and Fibrosis in Diabetic Kidney. Antioxidants (Basel) 2021;10:1356. [PMID: 34572988 DOI: 10.3390/antiox10091356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
39 Ouarné M, Pena A, Franco CA. From remodeling to quiescence: The transformation of the vascular network. Cells Dev 2021;:203735. [PMID: 34425253 DOI: 10.1016/j.cdev.2021.203735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
40 Crasto W, Patel V, Davies MJ, Khunti K. Prevention of Microvascular Complications of Diabetes. Endocrinol Metab Clin North Am 2021;50:431-55. [PMID: 34399955 DOI: 10.1016/j.ecl.2021.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
41 Abubakar A, Nazifi AB, Maje IM, Tanko Y, Anuka JA, Abdurahman EM. Chlorophytum alismifolium mitigates microvascular complications of type 2 diabetes mellitus: the involvement of oxidative stress and aldose reductase. Drug Metab Pers Ther 2021;37:69-80. [PMID: 35385895 DOI: 10.1515/dmpt-2021-0129] [Reference Citation Analysis]
42 Abubakar A, Nazifi AB, Maje IM, Tanko Y, Anuka JA, Abdurahman EM. Chlorophytum alismifolium mitigates microvascular complications of type 2 diabetes mellitus: the involvement of oxidative stress and aldose reductase. Drug Metab Pers Ther 2021. [PMID: 34392635 DOI: 10.1515/dmdi-2021-0129] [Reference Citation Analysis]
43 Marcovecchio ML. Importance of Identifying Novel Biomarkers of Microvascular Damage in Type 1 Diabetes. Mol Diagn Ther 2020;24:507-15. [PMID: 32613289 DOI: 10.1007/s40291-020-00483-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
44 Yaqub S, Hamid A, Kashif W, Razzaque MRA, Farooque A, Ahmed B, Ram N. Rapidly progressive diabetic kidney disease: South Asian experience. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-00975-z] [Reference Citation Analysis]
45 Patial V, Katoch S, Chhimwal J, Singh PP, Suresh PS, Padwad Y. Tinospora cordifolia activates PPARγ pathway and mitigates glomerular and tubular cell injury in diabetic kidney disease. Phytomedicine 2021;91:153663. [PMID: 34358759 DOI: 10.1016/j.phymed.2021.153663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Buades JM, Craver L, Del Pino MD, Prieto-Velasco M, Ruiz JC, Salgueira M, de Sequera P, Vega N. Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options? J Clin Med 2021;10:2943. [PMID: 34209083 DOI: 10.3390/jcm10132943] [Reference Citation Analysis]
47 Wang Y, Tan J, Xu C, Wu H, Zhang Y, Xiong Y, Yi C. Identification and construction of lncRNA-associated ceRNA network in diabetic kidney disease. Medicine (Baltimore) 2021;100:e26062. [PMID: 34087849 DOI: 10.1097/MD.0000000000026062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Duan S, Lu F, Song D, Zhang C, Zhang B, Xing C, Yuan Y. Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease. Front Endocrinol (Lausanne) 2021;12:661185. [PMID: 34177803 DOI: 10.3389/fendo.2021.661185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
49 Hassan M, Hatata EZ, Al-Arman M, Aboelnaga MM. Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients. Diabetes Metab Syndr 2021;15:102152. [PMID: 34186366 DOI: 10.1016/j.dsx.2021.05.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Wang R, Liu H. Association Between Serum Irisin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis. Horm Metab Res 2021;53:293-300. [PMID: 33962476 DOI: 10.1055/a-1475-4444] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
51 Gembillo G, Ingrasciotta Y, Crisafulli S, Luxi N, Siligato R, Santoro D, Trifirò G. Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia. Int J Mol Sci 2021;22:4824. [PMID: 34062938 DOI: 10.3390/ijms22094824] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
52 Ghaith N, Malaeb B, Itani R, Alnafea M, Al Faraj A. Correlation of Kidney Size on Computed Tomography with GFR, Creatinine and HbA1C for an Accurate Diagnosis of Patients with Diabetes and/or Chronic Kidney Disease. Diagnostics (Basel) 2021;11:789. [PMID: 33925666 DOI: 10.3390/diagnostics11050789] [Reference Citation Analysis]
53 Chen D, Liu Y, Chen J, Lin H, Guo H, Wu Y, Xu Y, Zhou Y, Zhou W, Lu R, Zhou J, Wu J. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes. Eur J Pharmacol 2021;902:174121. [PMID: 33901462 DOI: 10.1016/j.ejphar.2021.174121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
54 Natesan V, Kim SJ. Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management. Biomol Ther (Seoul) 2021;29:365-72. [PMID: 33888647 DOI: 10.4062/biomolther.2020.204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
55 Tan YM, Gao Y, Teo G, Koh HWL, Tai ES, Khoo CM, Choi KP, Zhou L, Choi H. Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy. Metabolites 2021;11:228. [PMID: 33918080 DOI: 10.3390/metabo11040228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
56 Chyła G, Sałaga-Zaleska K, Dąbkowski K, Kuchta A, Jankowski M. Suramin enhances the urinary excretion of VEGF-A in normoglycemic and streptozotocin-induced diabetic rats. Pharmacol Rep 2021;73:841-6. [PMID: 33635529 DOI: 10.1007/s43440-021-00236-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Skobeleva KV, Tyrtova LV. The effect of the components of the renin-angiotensinaldosterone system on the development of diabetic nephropathy in type 1 diabetes (review). Nefrologiâ (St -Peterbg ) 2021;25:43-51. [DOI: 10.36485/1561-6274-2021-25-2-43-51] [Reference Citation Analysis]
58 Li Y, Wang L, Xu B, Zhao L, Li L, Xu K, Tang A, Zhou S, Song L, Zhang X, Zhan H. Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy. J Diabetes Res 2021;2021:8891093. [PMID: 33628839 DOI: 10.1155/2021/8891093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
59 Palmer MB, Abedini A, Jackson C, Blady S, Chatterjee S, Sullivan KM, Townsend RR, Brodbeck J, Almaani S, Srivastava A, Avasare R, Ross MJ, Mottl AK, Argyropoulos C, Hogan J, Susztak K. The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort. Kidney Int Rep 2021;6:1066-80. [PMID: 33912757 DOI: 10.1016/j.ekir.2021.01.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
60 Jiang Z, Wang Y, Ding J, Yu S, Zhang J, Zhou H, Di J, Xing W. Susceptibility weighted imaging (SWI) for evaluating renal dysfunction in type 2 diabetes mellitus: a preliminary study using SWI parameters and SWI-based texture features. Ann Transl Med 2020;8:1673. [PMID: 33490185 DOI: 10.21037/atm-20-7121] [Reference Citation Analysis]
61 Hou NN, Kan CX, Huang N, Liu YP, Mao EW, Ma YT, Han F, Sun HX, Sun XD. Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes. World J Diabetes 2021; 12(1): 47-55 [PMID: 33520107 DOI: 10.4239/wjd.v12.i1.47] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Vázquez-Moreno M, Locia-Morales D, Peralta-Romero J, Sharma T, Meyre D, Cruz M, Flores-Alfaro E, Valladares-Salgado A. AGT rs4762 is associated with diastolic blood pressure in Mexicans with diabetic nephropathy. J Diabetes Complications 2021;35:107826. [PMID: 33423909 DOI: 10.1016/j.jdiacomp.2020.107826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Fakharzadeh S, Kalanaky S, Argani H, Dadashzadeh S, Torbati PM, Nazaran MH, Basiri A. Ameliorative effect of a nano chromium metal-organic framework on experimental diabetic chronic kidney disease. Drug Dev Res 2021;82:393-403. [PMID: 33230842 DOI: 10.1002/ddr.21759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Smyth LJ, Patterson CC, Swan EJ, Maxwell AP, McKnight AJ. DNA Methylation Associated With Diabetic Kidney Disease in Blood-Derived DNA. Front Cell Dev Biol 2020;8:561907. [PMID: 33178681 DOI: 10.3389/fcell.2020.561907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Mutter S, Valo E, Aittomäki V, Nybo K, Raivonen L, Thorn LM, Forsblom C, Sandholm N, Würtz P, Groop P. Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes.. [DOI: 10.1101/2020.10.21.20215921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Wang Y, Li N, Tian X, Lin L, Liang S, Zhao P, Dong Z, Wang Q, Li Q, Tang J, Luo Y. Evaluation of Renal Microperfusion in Diabetic Patients With Kidney Injury by Contrast-Enhanced Ultrasound. J Ultrasound Med 2021;40:1361-8. [PMID: 33035374 DOI: 10.1002/jum.15516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Cleveland KH, Brosius FC 3rd, Schnellmann RG. Regulation of mitochondrial dynamics and energetics in the diabetic renal proximal tubule by the β2-adrenergic receptor agonist formoterol. Am J Physiol Renal Physiol 2020;319:F773-9. [PMID: 32954853 DOI: 10.1152/ajprenal.00427.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
68 Xu X, Carvalho V, Wang X, Qiu S, Sun Z. Lipohypertrophy: prevalence, clinical consequence, and pathogenesis. Chinese Medical Journal 2021;134:47-49. [DOI: 10.1097/cm9.0000000000000970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Zhu H, Wan H, Wu L, Li Q, Liu S, Duan S, Huang Z, Zhang C, Zhang B, Xing C, Yuan Y. Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy. BMC Nephrol 2020;21:274. [PMID: 32664896 DOI: 10.1186/s12882-020-01931-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Tombak A, Kiykim AA, Çimen MBY, Sungur MA. Types, Courses and Outcomes of Renal Failure in Hospitalized Patients: A Single Center Experience. Düzce Tıp Fakültesi Dergisi 2019. [DOI: 10.18678/dtfd.531909] [Reference Citation Analysis]